Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2002;33:1963-1968
doi: 10.1161/01.STR.0000023445.20454.A8
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Anderson, D.C.
Right arrow Articles by Blakely, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Anderson, D.C.
Right arrow Articles by Blakely, J.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Atrial Fibrillation
*Retinal Disorders
Related Collections
Right arrow Acute Stroke Syndromes
Right arrow Carotid Stenosis
Right arrow Embolic stroke
Right arrow Transient Ischemic Attacks

(Stroke. 2002;33:1963.)
© 2002 American Heart Association, Inc.


Original Contributions

Occurrence of Hemispheric and Retinal Ischemia in Atrial Fibrillation Compared With Carotid Stenosis

D.C. Anderson, MD; L.J. Kappelle, MD; M. Eliasziw, PhD; V.L. Babikian, MD; L.A. Pearce, MS H.J.M. Barnett, MD

From Hennepin County Medical Center and University of Minnesota, Minneapolis (D.C.A.); University Medical Center Utrecht, Utrecht, the Netherlands (L.J.K.); John P. Robarts Research Institute (M.E., H.J.M.B.) and Department of Epidemiology and Biostatistics (M.E.), University of Western Ontario, London, Ontario, Canada; Boston University School of Medicine, Boston, Mass (V.L.B.); and Axio Research Corporation, Seattle, Wash (L.A.P.).

Reprint requests to David C. Anderson, MD, Hennepin County Medical Center, Department of Neurology, 701 Park Ave S, Minneapolis, MN 55415. E-mail ander012{at}tc.umn.edu

Background and Purpose The goal of this study was to examine the hypotheses that retinal ischemia is caused more often by carotid atherosclerosis than by atrial fibrillation and that the odds of retinal events compared with hemispheric events increase with worsening carotid stenosis.

Methods We used data from the Stroke Prevention in Atrial Fibrillation (SPAF) I through III trials and North American Symptomatic Carotid Endarterectomy Trial (NASCET), calculating hemispheric:retinal (H:R) odds for the territory of ischemic events during follow-up in patients with atrial fibrillation and medically treated 50% to 99% carotid stenosis or occlusion in the respective trials.

Results The H:R odds were 25:1 in the SPAF aspirin-assigned patients and 2:1 for NASCET vessels. In NASCET patients, the H:R odds of recurrent ischemic events were 1:4 for vessels randomized initially for retinal symptoms compared with 6:1 for those randomized for hemispheric events (significant difference; P<0.001). Moreover, the H:R odds of first events in the territory of the contralateral asymptomatic artery were 1:1 if the randomized vessel had retinal symptoms compared with 4:1 if the randomized vessel had hemispheric symptoms (significant difference; P<0.01). Increasing carotid stenosis in the 50% to 99% range had no effect on H:R odds (P=0.8).

Conclusions These findings confirm that retinal symptoms are more typical of carotid stenosis. Hemodynamic effects do not appear to be more important in the pathogenesis of retinal events than hemispheric ones in carotid stenosis. The retinal versus hemispheric location of initial symptoms is strongly predictive of the location of subsequent events in patients with carotid stenosis, even when new symptoms are contralateral to the original ones.

Editorial Comment

John Blakely, BA, MD, FRCPC, Guest Editor



This article has been cited by other articles:


Home page
Mayo Clin Proc.Home page
M. A. Crandall, D. J. Bradley, D. L. Packer, and S. J. Asirvatham
Contemporary Management of Atrial Fibrillation: Update on Anticoagulation and Invasive Management Strategies
Mayo Clin. Proc., July 1, 2009; 84(7): 643 - 662.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
Y. L Bayard, S. H Ostermayer, and H. Sievert
Alternatives to warfarin in atrial fibrillation: drugs and devices
Heart, September 1, 2008; 94(9): 1113 - 1116.
[Full Text] [PDF]


Home page
StrokeHome page
I. Thyer, P. Kovoor, J. J. Wang, B. Taylor, A. Kifley, R. Lindley, P. Mitchell, and A. Thiagalingam
Coronary Catheterisation Does Not Lead to Retinal Artery Emboli in Short-Term Follow-Up of Cardiac Patients
Stroke, August 1, 2007; 38(8): 2370 - 2352.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
E L L M De Schryver, A Algra, R C J M Donders, J van Gijn, and L J Kappelle
Type of stroke after transient monocular blindness or retinal infarction of presumed arterial origin
J. Neurol. Neurosurg. Psychiatry, June 1, 2006; 77(6): 734 - 738.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
R. G. Hart, L. A. Pearce, and P. J. Koudstaal
Transient Ischemic Attacks in Patients With Atrial Fibrillation: Implications for Secondary Prevention: The European Atrial Fibrillation Trial and Stroke Prevention in Atrial Fibrillation III Trial
Stroke, April 1, 2004; 35(4): 948 - 951.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
R. G. Hart, J. L. Halperin, L. A. Pearce, D. C. Anderson, R. A. Kronmal, R. McBride, E. Nasco, D. G. Sherman, R. L. Talbert, J. R. Marler, et al.
Lessons from the Stroke Prevention in Atrial Fibrillation Trials
Ann Intern Med, May 20, 2003; 138(10): 831 - 838.
[Abstract] [Full Text] [PDF]